Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-...
Q1 2026
Apr 1, 2026
FY 2025
Q2 2025
Aug 12, 2025
FY 2024
Mar 24, 2025
Q4 2024